CompoAtlas

Genacol Membrane de Coquille d'oeuf

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Membrane de coquille d'oeuf de poule partiellement hydrolysée

Source : Gallus gallus - Coquille d'oeuf

500 mgNot calculated
Membrane de coquille d'oeuf de poule partiellement hydrolysée

Source : Partially hydrolysed chicken eggshell membrane

500 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Gélatine, Cellulose microcristalline, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in postmenopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in postmenopausal women. Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Helps to reduce joint pain and reduce stiffness. Clinically proven to help reduce joint pain in 7- 10 days. Helps to reduce joint pain and reduce stiffness. Helps to reduce pain associated with osteoarthritis. Helps to reduce joint pain associated with osteoarthritis. Helps to reduce stiffness associated with osteoarthritis. Helps to relieve joint pain and stiffness associated with osteoarthritis. Starts to help reduce joint stiffness due to moderate intensity aerobic exercise as quickly as 5 days.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Genacol ActiMouv, Genacol ActionFlex, Genacol Activ-flex, Genacol Anti-Douleur Basics, Genacol Anti-Douleur Basique, Genacol Anti-Douleur Classic, Genacol Anti-Douleur Econo, Genacol Anti-Douleur Essentiel, Genacol Anti-Douleur Light, Genacol Anti-Douleur Simple, Genacol Anti-Douleur Valeur, Genacol Anti-Douleur Value, Genacol Arthri-Flex, Genacol Arthri-support, Genacol Arti-support, Genacol ArtiFlex, Genacol BioFlex, Genacol CartiFlex, Genacol CartiSoin, Genacol Flex, Genacol Flex-Support, Genacol FlexMouv, Genacol Flexi-Mobilité, Genacol FlexiFit, Genacol FlexiFlex, Genacol FlexiSoin, Genacol Mobili-t, Genacol Mobilité, Genacol MouvSupport, Genacol NaturFlex, Genacol OvoFlex
Licence holder
Genacol Group Inc.
NPN or DIN-HM
80137551
Status
Active licence
Licence date
3 January 2025
Revision date
10 February 2026
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80137551

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Genacol Membrane de Coquille d'oeuf”, https://compoatlas.com/en/supplements/canada/80137551-genacol-membrane-de-coquille-d-oeuf, updated 10 February 2026.

Enter to analyse, Shift+Enter for a new line